Welcome to the BIDMC DiAD clinic!
To refer a patient to our clinic for consideration of disease-modifying treatments, please fill out patient information below.
We will be offering novel treatments following the FDA and our pharmacy's appropirate use criteria, which include but are not limited to:
- A diagnosis of MCI or mild dementia due to Alzhiemer's disease, corresponding to an approx MMSE > 20
We are not able to offer treatment at this time for patients with:
- Active treatment with anticoagulation
- APOE4/4 genotype